Luminal B breast cancer expresses the hormone receptor ER and it can be: a) HER2-negative with at least one of: PR low to none (<20%) and the biomarker Ki-67 highly expressed (≥ 20%) or b) HER2-positive with variable levels of PR and Ki-67 [7]. Here, ERBB2 is linked to breast carcinoma.